FDA Enforcement Class III Terminated

VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.

Recall: Z-2779-2016 · Reported September 21, 2016

Enforcement

Recall Number
Z-2779-2016
Event ID
73989
Classification
Class III
Status
Terminated
Product Type
Devices
Firm
Biomerieux France Chemin De L'Or
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 21, 2016
Initiation Date
April 15, 2016
Classification Date
September 9, 2016
Termination Date
July 21, 2017
Address
Chemin De L'Orme, N/A, Marcy L'Etoile, N/A, N/A, France

Description

VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.

Reason

Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.

Code Info

Reference number: 30449-01, Lot #1004474560.

Distribution

US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.

Quantity

229 kits